US Military Casualty Statistics, and More from CRS
A sobering compilation of statistics on injuries sustained by U.S. military personnel in Iraq and Afghanistan was updated this week by the Congressional Research Service based in part on data that CRS gathered from the Pentagon.
“This report includes statistics on post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), amputations, evacuations, and the demographics of casualties,” the CRS report said. “Some of these statistics are publicly available at the Department of Defense’s (DOD’s) website, whereas others have been obtained through contact with experts at DOD.” See U.S. Military Casualty Statistics: Operation New Dawn, Operation Iraqi Freedom, and Operation Enduring Freedom, February 5, 2013.
Another newly updated CRS report presents an informative and diverting account of politics in China.
“China’s Communist Party dominates state and society in China, is committed to maintaining a permanent monopoly on power, and is intolerant of those who question its right to rule. Nonetheless, analysts consider China’s political system to be neither monolithic nor rigidly hierarchical. Jockeying among leaders and institutions representing different sets of interests is common at every level of the system.” See Understanding China’s Political System, January 31, 2013.
And for good measure there is a CRS report on the legal foundation for public access to government records. See Access to Government Information In the United States: A Primer, January 16, 2013.
There is no legal foundation that would guarantee public access to CRS reports. So they have to be obtained through alternate channels.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.